- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Keyword
-
SARS-CoV-2
Proteasen
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2023
- Creator
- Contributor
-
Schubert, Ulrich
Winkler, Thomas
- URN
-
urn:nbn:de:bvb:29-opus4-214593
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:57 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Große, Maximilian
- Schubert, Ulrich
- Winkler, Thomas
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2023
Other Objects (12)
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Lectin from Triticum vulgaris (WGA) as an antiviral agent against SARS-CoV-2
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Photodynamic inactivation of SARS-CoV-2 infectivity and antiviral treatment effects in vitro
Presentations of SARS-CoV-2 infections in children and adolescents : = Manifestationen von SARS-CoV-2 Infektionen bei Kindern und Jugendlichen
Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Lectin from Triticum vulgaris (WGA) as an antiviral agent against SARS-CoV-2
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Photodynamic inactivation of SARS-CoV-2 infectivity and antiviral treatment effects in vitro
Presentations of SARS-CoV-2 infections in children and adolescents : = Manifestationen von SARS-CoV-2 Infektionen bei Kindern und Jugendlichen
Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Lack of antiviral activity of darunavir against SARS-CoV-2
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Lectin from Triticum vulgaris (WGA) as an antiviral agent against SARS-CoV-2
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro
Photodynamic inactivation of SARS-CoV-2 infectivity and antiviral treatment effects in vitro
Presentations of SARS-CoV-2 infections in children and adolescents : = Manifestationen von SARS-CoV-2 Infektionen bei Kindern und Jugendlichen
Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform